Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 8/20 | 0.72 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.35 |
| ▸ | HEXB | P07686 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12331389 | 1.00 | OGA (0.72) | OGACHIAHEXBGAA | |
| SCHEMBL2439536 | 0.86 | OGA (0.75) | OGACHIAHEXBGAA | |
| SCHEMBL12331252 | 0.86 | OGA (0.75) | OGACHIAHEXBGAA | |
| Allosamizoline SCHEMBL12331251 | 0.84 | OGA (1.00) | OGACHIAHEXBGAA | |
| Allosamizoline SCHEMBL691526 | 0.84 | OGA (1.00) | OGACHIAHEXBGAA | |
| Allosamizoline SCHEMBL2441099 | 0.84 | OGA (1.00) | OGACHIAHEXBGAA | |
| SCHEMBL2442998 | 0.72 | OGA (0.55) | OGAHEXBGAA | |
| SCHEMBL12331388 | 0.72 | OGA (0.55) | OGAHEXBGAA | |
| SCHEMBL2637573 | 0.72 | OGA (0.62) | OGAHEXB | |
| SCHEMBL12302368 | 0.71 | OGA (0.58) | OGAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079868-B2 | Selective glycosidase inhibitors and uses thereof | SIMON FRASER UNIVERSITY (CA) | 2015-07-14 | — | — | US | disclosed |
| US-9079868-B2 | Selective glycosidase inhibitors and uses thereof | SIMON FRASER UNIVERSITY (CA) | 2015-07-14 | — | — | US | disclosed |
| US-20110237631-A1 | Selective Glycosidase Inhibitors and Uses Thereof | SIMON FRASER UNIVERSITY (CA) | 2011-09-29 | — | — | US | disclosed |
| US-20110237631-A1 | Selective Glycosidase Inhibitors and Uses Thereof | SIMON FRASER UNIVERSITY (CA) | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237631-A1 | Selective Glycosidase Inhibitors and Uses Thereof | ENGASE, OGA, GALE | OGA 2/4885CHIA 87/4885HEXB 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.